STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
260
13F, latest reported quarter
Conversions, 180 days
12
Codes C/M, not in net · $0 priced
What the filings say about CFR
Insiders, 180 days
-$124.1K net sold
1 seller · 0% of sales under a 10b5-1 plan
Cullen/frost Bankers insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, CULLEN/FROST BANKERS, INC. insiders sold a net $124.1K of stock across 58 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 0.0% of the 2,024 shares held after it.
1 other insider sold within 30 days.
260 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: GEVP, Culture & People Dev. Pullin Ericka Lynn sold about $44 of CFR on Dec 12, 2025; 1 other insider sold within 30 days and 260 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 18.4% of the 3,795 shares held after it.
1 other insider sold within 30 days.
260 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Group EVP General Counsel/Sec Rhodes Coolidge E JR sold about $88.9K of CFR on Dec 9, 2025; 1 other insider sold within 30 days and 260 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 33.7% of the 5,545 shares held after it.
No other insider bought within 30 days.
260 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Accounting Officer Henson Matthew Bradley bought about $31.7K of CFR on May 2, 2025, the largest insider purchase at the company since 2023; 260 funds added in the latest 13F quarter.
58 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
CFR planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
CFR mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Innovator S&P Investment Grade Preferred ETF
$2.6M position · as of 2026-07-31
3.8%
LK Balanced Fund
$772.6K position · as of 2026-06-30
2.9%
Hilton Small-MidCap Opportunity ETF
$4.0M position · as of 2026-07-31
2.8%
Mairs & Power Small Cap Fund
$6.6M position · as of 2026-06-30
2.4%
Pear tree polaris small cap fund
$2.3M position · as of 2026-06-30
2.2%
Timothy Plan Large/Mid Cap Value Fund
$7.1M position · as of 2026-06-30
2.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Mr. Green
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$7.6M
$7.4M
$2.1M
+68%
+125%
2024
$6.7M
$7.7M
$2.1M
+60%
+45%
2023
$6.5M
$6.8M
$1.9M
+25%
+5%
2022
$6.4M
$7.6M
$2.0M
+49%
-6%
2021
$5.2M
$8.1M
$1.5M
+37%
+17%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $124.1K sold by insiders over 180 days, 260 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$2.3B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM CFR
FY Dec 2025
$2.2B
FY Dec 2024
$2.1B
FY Dec 2023
$2.0B
FY Dec 2022
$1.7B
FY Dec 2021
$1.4B
Jun 2026
$576.0M
Mar 2026
$574.8M
Dec 2025
$580.9M
Sep 2025
$567.3M
Jun 2025
$546.9M
Mar 2025
$540.2M
Dec 2024
$536.3M
Sep 2024
$518.0M
At each fiscal year end
Single quarter
Net margin, TTM
+29.7%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM CFR
FY Dec 2025
+29.0%
FY Dec 2024
+28.2%
FY Dec 2023
+30.1%
FY Dec 2022
+34.1%
FY Dec 2021
+32.3%
Jun 2026
+29.9%
Mar 2026
+29.7%
Dec 2025
+28.6%
Sep 2025
+30.7%
Jun 2025
+28.7%
Mar 2025
+27.9%
Dec 2024
+28.9%
Sep 2024
+28.3%
At each fiscal year end
Single quarter
Free cash flow, TTM
$541.5M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM CFR
FY Dec 2025
$127.3M
FY Dec 2024
$861.8M
FY Dec 2023
$320.2M
FY Dec 2022
$620.1M
FY Dec 2021
$582.4M
Jun 2026
-$7.1M
Mar 2026
$198.7M
Dec 2025
$138.2M
Sep 2025
$211.7M
Jun 2025
$114.5M
Mar 2025
-$337.1M
Dec 2024
$26.7M
Sep 2024
$281.9M
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity CFR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt CFR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+15.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity CFR
FY Dec 2025
+15.3%
FY Dec 2024
+15.3%
FY Dec 2023
+17.4%
FY Dec 2022
+15.3%
FY Dec 2021
+10.1%
Jun 2026
+15.5%
Mar 2026
+15.5%
Dec 2025
+15.3%
Sep 2025
+14.8%
Jun 2025
+15.5%
Mar 2025
+15.4%
Dec 2024
+15.3%
Sep 2024
+14.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+1.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets CFR
FY Dec 2025
+1.2%
FY Dec 2024
+1.1%
FY Dec 2023
+1.2%
FY Dec 2022
+1.1%
FY Dec 2021
+1.0%
Jun 2026
+1.3%
Mar 2026
+1.3%
Dec 2025
+1.2%
Sep 2025
+1.2%
Jun 2025
+1.2%
Mar 2025
+1.2%
Dec 2024
+1.1%
Sep 2024
+1.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital CFR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed CFR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
14.99x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing CFR
FY Dec 2025
12.77x
FY Dec 2024
15.14x
FY Dec 2023
11.91x
FY Dec 2022
15.18x
FY Dec 2021
18.65x
Jun 2026
14.60x
Mar 2026
13.35x
Dec 2025
12.77x
Sep 2025
13.04x
Jun 2025
13.84x
Mar 2025
13.74x
Dec 2024
15.14x
Sep 2024
13.86x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value CFR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+5.5%
TTM free cash flow over market value at close 2026-10-26
FCF yield CFR
FY Dec 2025
+1.6%
FY Dec 2024
+10.0%
FY Dec 2023
+4.6%
FY Dec 2022
+7.2%
FY Dec 2021
+7.3%
Jun 2026
+5.6%
Mar 2026
+7.7%
Dec 2025
+1.6%
Sep 2025
+0.2%
Jun 2025
+1.0%
Mar 2025
+0.9%
Dec 2024
+10.0%
Sep 2024
+9.9%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
1.08x
P/E over trailing EPS growth of 14%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing CFR
FY Dec 2025
1.08x
FY Dec 2024
n/a
FY Dec 2023
3.50x
FY Dec 2022
0.50x
FY Dec 2021
0.58x
Jun 2026
1.05x
Mar 2026
1.05x
Dec 2025
1.08x
Sep 2025
0.64x
Jun 2025
1.05x
Mar 2025
1.82x
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CFR ranks highest on institutional and government (86th percentile) and profitability (80th), and lowest on insider conviction (28th), among Banks peers.
Profitability
80
Inputs
Return on equity+15.5% · 90 pct, sector of 327
Return on assets+1.3% · 70 pct, sector of 334
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Growth
78
Inputs
Revenue growth, YoY+14.4% · 78 pct, sector of 151
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
28
Inputs
Net Form 4 buying (codes P and S), 180d-$124K · 56 pct, sector of 274
Insider buyers, 180d0 · 0 pct, sector of 274
Institutional and government
86
Inputs
Funds adding, latest quarter260 · 86 pct, sector of 257
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
37
Inputs
Short interest, % of float+7.2% · 11 pct, sector of 378
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+9.0% · 63 pct, sector of 127
2 not measured: Financial health, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CFR filings, in plain words
Are Cullen/frost Bankers insiders buying or selling CFR?
In the 180 days to 2026-10-28, Cullen/frost Bankers insiders were net sellers, a net $124.1K across purchases and sales reported on Form 4, by 1 seller.
Read the full summary
In the 180 days to 2026-10-28, Cullen/frost Bankers insiders were net sellers of CFR, a net $124.1K across purchases and sales reported on Form 4 by 1 seller. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.